MEDPLUS

Medplus Health Services Share Price

₹733.00 -5.8 (-0.79%)

21 Nov, 2024 14:12

SIP TrendupStart SIP in MEDPLUS

Start SIP

Performance

  • Low
  • ₹721
  • High
  • ₹740
  • 52 Week Low
  • ₹599
  • 52 Week High
  • ₹849
  • Open Price₹734
  • Previous Close₹739
  • Volume278,645

Investment Returns

  • Over 1 Month + 7.5%
  • Over 3 Month + 14.67%
  • Over 6 Month + 5.24%
  • Over 1 Year -12.43%
SIP Lightning

Smart Investing Starts Here Start SIP with Medplus Health Services for Steady Growth!

Invest Now

Medplus Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 87.4
  • PEG Ratio
  • 1.2
  • Market Cap Cr
  • 8,763
  • P/B Ratio
  • 5.6
  • Average True Range
  • 23.45
  • EPS
  • 8.38
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.61
  • RSI
  • 71.33
  • MFI
  • 91.85

Medplus Health Services Financials

Medplus Health Services Technicals

EMA & SMA

Current Price
₹733.00
-5.8 (-0.79%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹684.69
  • 50 Day
  • ₹677.85
  • 100 Day
  • ₹679.27
  • 200 Day
  • ₹692.18

Resistance and Support

734.07 Pivot Speed
  • R3 780.53
  • R2 763.47
  • R1 751.13
  • S1 721.73
  • S2 704.67
  • S3 692.33

What's your outlook on Medplus Health Services?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medplus Health Services Ltd. is one of India’s largest pharmacy retail chains, offering a wide range of medicines, healthcare products, and diagnostic services. With an extensive network of stores, it provides convenient, affordable healthcare solutions across India.

Medplus Health Services has an operating revenue of Rs. 5,996.97 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 8% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 96 indicates it belongs to a poor industry group of Retail-Drug Stores and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medplus Health Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-02 Quarterly Results
2024-05-28 Audited Results
2024-02-21 Others Inter alia, to discuss the management recommendation to not proceed with the approval for Qualified Institutional Placement (QIP) received from shareholders on November 30, 2023.
2024-02-02 Quarterly Results

Medplus Health Services F&O

Medplus Health Services Shareholding Pattern

40.39%
18.08%
3.03%
14.72%
11.84%
11.94%

About Medplus Health Services

  • NSE Symbol
  • MEDPLUS
  • BSE Symbol
  • 543427
  • ISIN
  • INE804L01022

Similar Stocks to Medplus Health Services

Medplus Health Services FAQs

Medplus Health Services share price is ₹733 As on 21 November, 2024 | 13:58

The Market Cap of Medplus Health Services is ₹8762.8 Cr As on 21 November, 2024 | 13:58

The P/E ratio of Medplus Health Services is 87.4 As on 21 November, 2024 | 13:58

The PB ratio of Medplus Health Services is 5.6 As on 21 November, 2024 | 13:58

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23